A meta-analysis of 511 studies on US COVID-19, respiratory syncytial virus (RSV), and influenza vaccines find meaningful protection against severe disease and hospitalization, evidence that can help ...
Meta Platforms (META) will be releasing its third-quarter earnings report on Wednesday after the closing bell. Analysts ...
New pooled data confirm that endovascular thrombectomy improves survival and function in large-core stroke, offering hope for ...
Shares in Meta Platforms (META) are down 12% on Thursday, extending Wednesday's post-market losses, after the social media ...
Antidepressants show clinically significant and highly heterogeneous effects on cardiometabolic parameters, weight, and blood ...
Meta Platforms shows strong ad growth, Family of Apps engagement, and high ROIC with long-term value potential. Learn why META stock is a buy.
The firm has accrued approximately $99 billion in value over the last 8 days, and its current market capitalization stands at roughly $1.9 trillion..
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback